A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension
← catalyst calendarSponsored by AstraZeneca (industry) · AZN — their whole pipeline →.
Phase
Phase 3
Status
Completed
Study type
Interventional
Design
Randomized · Quadruple · Treatment
Enrollment
218actual
Sites
102
Countries
Argentina, Australia, Belgium +19
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-03-01 | actual | When the study began enrolling |
| Primary completion | 2025-08-17 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-08-17 | actual | The whole study's end, after follow-up |
| First posted | 2023-12-13 | actual | When this record first appeared on the registry |
| Results posted | 2026-08-06 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-08-06 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Resistant Hypertension
Interventions
- Drug: Baxdrostat — also filed as CIN-107
- Drug: Placebo
Primary outcome
what the primary-completion date above is the date OFLeast Square Mean Difference for Change From Baseline in Ambulatory 24-hour Average SBP at Week 12: Treatment Policy Strategy
measured Baseline to week 12
Posted documents
hosted by the registry — we link, never re-serveStudy Protocolposted 2024-05-29 · 1.0 MB · Prot_004.pdf
Statistical Analysis Planposted 2025-07-29 · 891 KB · SAP_005.pdf
Publications
- PMID 41794437 — linked by the registry
- PMID 40913594 — linked by the registry
- PMID 40850955 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · AZN's whole pipeline · Catalyst calendar · Every registered study · What changed